Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships:

George Bakris, MD, is a consultant for Boehringer Ingelheim.

Björn Dahlöf, MD, has been a member of the Speakers' Bureau for Novartis, Boehringer Ingelheim and Pfizer; and has served as a consultant for Novartis, Boehringer Ingelheim and Daiichi-Sankyo.

Kevin D. O'Brien, MD, is a consultant/speaker for AstraZeneca, Boehringer-Ingelheim, Merck, Novartis and sanofi-aventis; and receives research support from the NHLBI and the NIDDK.

Jeffrey L. Probstfield, MD, has served as a consultant for Boehringer Ingelheim.

Michael A. Weber, MD, is a member of the Speakers' Bureau for Boehringer Ingelheim, Bristorl Myers Squibb, Daiichi-Sankyo, Forest Pharmaceuticals, GlaxoSmithKline, Novartis and sanofi-aventis; and serves as a consultant for Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Forest Pharmaceuticals, Gilead, Novarties, and Takeda Pharmaceuticals.